Mixed-type liposarcoma is a very rare and complex form of cancer that develops in fatty tissues, characterized by the presence of different liposarcoma subtypes within the same tumor. This unusual combination makes it one of the most challenging forms of soft tissue sarcoma to diagnose and treat, requiring specialized expertise and careful management.

What is Mixed-Type Liposarcoma?

Mixed-type liposarcoma is an uncommon variant of liposarcoma, which is a cancer that begins in fat cells. What makes this type unique is that it contains areas of two or more different liposarcoma subtypes within a single tumor. Most commonly, mixed-type liposarcoma combines regions of well-differentiated liposarcoma with areas of myxoid or round cell liposarcoma, though other combinations can occur^[3][8].

The presence of multiple subtypes in one tumor creates diagnostic challenges because each component may behave differently. One part of the tumor might grow slowly and remain localized, while another section could be more aggressive and prone to spreading. This biological complexity means that mixed-type liposarcoma requires careful evaluation by experienced specialists who understand how to identify and assess these different tissue patterns^[2].

Epidemiology

Mixed-type liposarcoma is exceptionally rare, even among liposarcomas, which themselves are uncommon cancers. While liposarcoma as a whole affects approximately 2,000 people each year in the United States, mixed-type cases represent only a small fraction of these diagnoses^[1][9]. The exact incidence of mixed-type liposarcoma is difficult to determine because it is so infrequent that many medical centers may only encounter a handful of cases over many years.

Liposarcoma in general predominantly affects men between the ages of 50 and 65 years, though one subtype called myxoid liposarcoma tends to occur in younger adults between ages 35 and 55^[1][11]. Since mixed-type liposarcoma often involves myxoid components, the age distribution can vary depending on which subtypes are combined within the tumor. This cancer is rarely seen in children, but when it does occur in younger patients, it typically appears during adolescence^[1].

Causes

The exact causes of mixed-type liposarcoma remain largely unknown. Like other liposarcomas, mixed-type tumors arise from genetic changes that occur in fat cells or their precursor cells. However, no specific genetic causes have been clearly identified for why liposarcoma develops in the first place^[1][9].

What researchers do know is that mixed-type liposarcomas carry the genetic signatures of their component subtypes. For example, when well-differentiated liposarcoma is present, there is typically an amplification of genes called MDM2 and CDK4 located on chromosome 12. These genes produce proteins that interfere with normal cell growth control. Meanwhile, areas of myxoid liposarcoma within the same tumor show different genetic alterations, specifically translocations involving genes called FUS and DDIT3 (also known as CHOP)^[3][8][13].

This means that mixed-type liposarcoma contains cells with fundamentally different genetic mistakes, all existing within one tumor mass. How and why these different genetic patterns develop together in the same location is not well understood and remains an active area of research.

Risk Factors

Because mixed-type liposarcoma is so rare, specific risk factors have not been clearly established. However, based on what is known about liposarcomas in general, certain factors may increase a person’s risk of developing this type of cancer.

Prior exposure to radiation therapy is one recognized risk factor. People who have received radiation treatment for a previous cancer have an increased chance of developing sarcomas, including liposarcoma, in the area that was radiated. This effect typically does not appear until several years after the radiation exposure^[23].

Exposure to certain chemical substances has also been linked to increased sarcoma risk. Vinyl chloride, a chemical used in making plastics, is one substance that has been associated with soft tissue sarcomas in people who work with it regularly^[5][12].

Some inherited genetic conditions may predispose individuals to developing soft tissue sarcomas, though these conditions are rare and account for only a small percentage of cases. Most people who develop mixed-type liposarcoma do not have any identifiable risk factors or family history of the disease^[5][12].

Symptoms

In the early stages, mixed-type liposarcoma typically produces no symptoms at all. The tumor often goes unnoticed for months or even years because it grows deep within the body’s tissues and causes no discomfort. Symptoms usually only become apparent once the tumor has grown large enough to press against nearby structures or create a visible bulge^[1][9].

The symptoms that eventually develop depend heavily on where the tumor is located. Mixed-type liposarcoma can occur in the deep soft tissues of the arms or legs, particularly the thigh. When the tumor grows in a limb, the most common initial sign is a growing lump under the skin. This lump is usually painless at first and feels firm to the touch. As it enlarges, it may begin to cause pain in the affected area, swelling, or weakness of the limb. If the tumor presses on a nerve, it can cause numbness, tingling, or reduced ability to move the affected body part^[1][9][14].

When mixed-type liposarcoma develops in the abdomen, particularly in the space behind the abdominal organs called the retroperitoneum, it can grow to a very large size before being detected. Symptoms of abdominal liposarcoma may include abdominal pain, visible swelling or enlargement of the belly, feeling full quickly after eating small amounts of food, constipation, nausea, or unintended weight loss. In some cases, the tumor may cause blood to appear in the stool or vomit^[1][9].

Some people with mixed-type liposarcoma may also experience non-specific symptoms that can accompany many types of cancer. These include persistent fatigue, unexplained fevers, chills, night sweats, and unintended weight loss. However, these symptoms are less common and usually indicate more advanced disease^[1][9].

Prevention

Because the exact causes of mixed-type liposarcoma are not known, there are no proven strategies to prevent this disease from developing. Unlike some cancers that can be prevented through lifestyle changes or vaccination, liposarcoma does not have known modifiable risk factors that could be targeted for prevention.

However, people who have received radiation therapy in the past should be aware of their slightly increased risk for developing soft tissue sarcomas, including liposarcoma. These individuals should maintain regular follow-up care with their healthcare providers and report any new lumps or masses that develop, particularly in areas that were previously radiated^[23].

For people who work with potentially hazardous chemicals like vinyl chloride, following proper safety procedures and using appropriate protective equipment may help reduce exposure and potentially lower cancer risk. However, occupational exposure to these substances accounts for only a very small number of sarcoma cases^[5][12].

Early detection, while not prevention, can be valuable. Being aware of your body and noticing any unusual lumps, particularly those that are deep-seated, firm, or growing over time, and bringing them to medical attention promptly can lead to earlier diagnosis. Earlier diagnosis may allow for treatment when the tumor is smaller and has not spread, which typically leads to better outcomes^[1].

Pathophysiology

The pathophysiology of mixed-type liposarcoma is complex because it involves understanding how multiple different types of cancerous fat cell tumors can coexist within a single mass. Each component of the tumor has undergone different genetic changes that cause the cells to grow abnormally and ignore the body’s normal signals to stop dividing or die.

In the well-differentiated liposarcoma portions of a mixed-type tumor, cells have extra copies of certain genes on chromosome 12, particularly MDM2 and CDK4. The MDM2 protein normally regulates another protein called p53, which acts as a “brake” on cell division and helps damaged cells die. When MDM2 is overproduced due to gene amplification, it excessively breaks down p53, removing this important safety mechanism and allowing cells to continue dividing when they shouldn’t. Similarly, extra copies of CDK4 push cells through their growth cycle faster than normal, promoting uncontrolled cell multiplication^[5][12][13].

In the myxoid liposarcoma areas, a different genetic alteration is at work. Parts of two genes, FUS and DDIT3, break off and join together abnormally, creating what’s called a fusion gene. This fusion creates a new protein that shouldn’t normally exist in cells. This abnormal protein interferes with normal fat cell development and causes cells to remain in an immature state where they continue to multiply instead of maturing into normal fat cells^[3][8][13].

The tumor itself disrupts normal body function mainly through its size and location. As it grows, it takes up space and can compress nearby structures. When a mixed-type liposarcoma develops in a limb, it may press on nerves causing pain or numbness, or on blood vessels affecting circulation. In the abdomen, a large tumor can compress the intestines affecting digestion, or press on other organs reducing their function. The tumor may also consume nutrients that the body needs for other functions^[1][14].

The presence of different genetic patterns within one tumor has important implications for behavior and treatment. Areas with more aggressive genetic signatures, like high-grade myxoid or round cell components, are more likely to invade surrounding tissues deeply or spread through the bloodstream to distant sites like the lungs. Meanwhile, well-differentiated areas tend to grow more slowly and are less likely to spread, though they have a higher tendency to grow back in the same location after removal^[2][8][13].